EX-10.7 12 d411577dex107.htm EXCLUSIVE LICENSE AGREEMENT DATED JUNE 28, 2007 Portions Subject to Confidential Treatment Request Under Rule 24b-2 EXCLUSIVE LICENSE AGREEMENT between Celator Pharmaceuticals and PRINCETON UNIVERSITY Concerning Princeton...Exclusive License Agreement • May 5th, 2020 • New Jersey
Contract Type FiledMay 5th, 2020 JurisdictionTHIS LICENSE AGREEMENT (the “Agreement”) is made and is effective as of the day of , 2007, by and between PRINCETON UNIVERSITY, having its Technology Licensing and Intellectual Property at 4 New South Building, Princeton, New Jersey 08544-0036, (hereinafter referred to as “Princeton”), and Celator Pharmaceuticals, a Delaware corporation having a principal place of business at 303B College Road East, Princeton, N.J. 08540 (hereinafter referred to as “Celator”).
EXCLUSIVE LICENSE AGREEMENT between Celator Pharmaceuticals and PRINCETON UNIVERSITYExclusive License Agreement • November 13th, 2012 • Celator Pharmaceuticals Inc • New Jersey
Contract Type FiledNovember 13th, 2012 Company JurisdictionTHIS LICENSE AGREEMENT (the “Agreement”) is made and is effective as of the day of , 2007, by and between PRINCETON UNIVERSITY, having its Technology Licensing and Intellectual Property at 4 New South Building, Princeton, New Jersey 08544-0036, (hereinafter referred to as “Princeton”), and Celator Pharmaceuticals, a Delaware corporation having a principal place of business at 303B College Road East, Princeton, N.J. 08540 (hereinafter referred to as “Celator”).